跳至主要内容
临床试验/CTRI/2023/05/052545
CTRI/2023/05/052545尚未招募3 期

Effect of Vamana Karma on the Disease Specific Biomarkers of Diabetes in Pre-Diabetic Patients - A Single Arm Open Label Clinical Trial.

Ayurvedic and Unani Tibbia Cpllege and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Patients of age group 18 to 60 years of either sex.
  • 2)The HbA1C levels should lie within the range of 5.7 to 6.4 ( A/C to American Diabetes Association, ADA ,2022 guidelines)

排除标准

  • 1)Patients with Type 1 or Type 2 diabetes mellitus.
  • 2)Patients with Gestational diabetes mellitus or pregnant women .
  • 3)Patients who are not fit for Vamana karma such as ati-sthula , ati- krisha, durbala and who will not be fit for vamana karma( at the time of enrollment) will not be included .
  • 4)Patients suffering from any chronic diseases such as bronchial asthma , COPD, chronic kidney disease , ischaemic heart diseases , fatty liver stage 3 and chronic illness of other body organs , uncontrolled high blood pressure ( >160/100 mm of Hg)
  • 5)Patients who are diagnosed with malignancy of any system.

研究者

发起方
Ayurvedic and Unani Tibbia Cpllege and Hospital

相似试验